Abstract
Chemotherapy of parasitic protists is limited by general toxicity, high expense and emergence of resistance to currently available drugs. Thus methods to identify new leads for further drug development are increasingly important. Previously, glucose transporters have been validated as new drug targets for protozoan parasites including Plasmodium falciparum, Leishmania mexicana and Trypanosoma brucei. A recently derived glucose transporter null mutant (Deltalmgt) of L. mexicana was used to functionally express various heterologous glucose transporters including those from T. brucei THT1, P. falciparum PfHT and human GLUT1-resulting in recovery of growth of the Deltalmgt null mutant in glucose replete medium. This heterologous expression system can be employed to screen for compounds that retard growth by inhibiting the expressed glucose transporter. The ability of this expression system to identify specific glucose transporter inhibitors was demonstrated using 3-O-undec-10-enyl-d-glucose, a previously described specific inhibitor of PfHT.
References
Sep 1, 1992·The Journal of protozoology·B H Ter Kuile, F R Opperdoes
Jul 1, 1987·Chemical & Pharmaceutical Bulletin·T IkekawaM Kosik
Feb 1, 1993·Molecular and Cellular Biology·F Bringaud, T Baltz
Dec 15, 1995·The Biochemical Journal·M P BarrettT Baltz
Aug 1, 1997·Biochemical Society Transactions·M MuecklerM Sato
Mar 6, 1999·The Journal of Biological Chemistry·C J WoodrowS Krishna
Jan 5, 2000·FEBS Letters·R WieczorkeE Boles
Feb 22, 2000·The Journal of Biological Chemistry·A Seyfang, S M Landfear
Aug 8, 2001·Microbes and Infection·E MatovuR Kaminsky
Sep 20, 2002·The Biochemical Journal·Thierry JoëtSanjeev Krishna
Mar 26, 2003·Proceedings of the National Academy of Sciences of the United States of America·Richard J S BurchmoreScott M Landfear
Jun 7, 2003·Proceedings of the National Academy of Sciences of the United States of America·Thierry JoetSanjeev Krishna
Mar 24, 2004·Biochemical Pharmacology·Laurent AzemaMichael P Barrett
Jan 19, 2006·Clinical Microbiology Reviews·Simon L CroftAlan H Fairlamb
Nov 15, 2006·Journal of Clinical Pharmacology·Johanna P Daily
Feb 3, 2007·Current Drug Targets·Kiaran Kirk, Kevin J Saliba
Feb 17, 2007·Life Sciences·Elaine Amaral LeiteVanessa C F Mosqueira
Jun 26, 2007·Bioorganic & Medicinal Chemistry Letters·Marina IonitaAsha Parbhu Patel
Aug 19, 2007·Physiology·Andrei R ManolescuChris Cheeseman
Citations
Dec 21, 2010·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Martin BlumeNishith Gupta
Jul 21, 2009·Eukaryotic Cell·Jeffrey Sabina, Victoria Brown
Jun 17, 2011·Malaria Journal·Ksenija SlavicHenry M Staines
Aug 9, 2012·Parasites & Vectors·Paula F dos SantosSilvane M F Murta
Apr 22, 2015·PloS One·Diana OrtizScott M Landfear
Jul 13, 2016·Cellular Microbiology·Patrícia MeirelesMiguel Prudêncio
Dec 30, 2017·PLoS Neglected Tropical Diseases·Diana OrtizScott M Landfear